July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
OCT Angiography: Characteristics of Choroidal Tumors before and after Photodynamic Therapy
Author Affiliations & Notes
  • Irene A Barbazetto
    Vitreous-Retina-Macula-Consultants of NY, New York, New York, United States
    Ophthalmology, NYU, New York, New York, United States
  • Footnotes
    Commercial Relationships   Irene Barbazetto, Roche/ Genentech (R)
  • Footnotes
    Support  Potential travel grant if selected by the Macula Foundation
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3640. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Irene A Barbazetto; OCT Angiography: Characteristics of Choroidal Tumors before and after Photodynamic Therapy. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3640.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : To evaluate vascular pattern and flow changes following photodynamic fherapy (PDT) for choroidal tumors using optical coherence tomography angiography (OCT-A).

Methods : This is a retrospective analysis of multimodal imaging of patients undergoing PDT for choroidal tumors. Imaging included Fluorescein and Indocyanine Green Angiography, Color and Autofluorescence as well as OCT-A imaging (Optovue RTVue XR Avanti (Optovue, Inc, Fremont, CA)).

Results : Seven eyes of 7 patients treated with Veteporfin mediated PDT for choroidal tumors (5 hemangioma, 1 amelanotic melanoma, 1 metastatic tumor) were evaluated. Image analysis pre- and post treatment revealed changes primarily in the choriocapillais (CC). One month following treatment, decreased density of smaller choroidal vessels was noted in all patients. Some of these changes seemed to be reversible on longer follow-up (> 3 months). While the number of cases did not allow to quantify dose-dependent changes, double fluenec PDT (100J/cm2) and repeated treatment may result in more profound vascular alterations.

Conclusions : OCT-A could be potentially useful in evaluating the therapeutic response and guiding dosimetry in patients undergoing PDT for choroidal tumors.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.